1. Hu, Yiyang, Gong, Chunli, Li, Zhibin, Yang, Shiming, Xiao, Yufeng. 2022. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. In Molecular cancer, 21, 34. doi:10.1186/s12943-022-01522-y. https://pubmed.ncbi.nlm.nih.gov/35114989/
2. Gallo, David, Young, Jordan T F, Fourtounis, Jimmy, Marshall, C Gary, Durocher, Daniel. 2022. CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition. In Nature, 604, 749-756. doi:10.1038/s41586-022-04638-9. https://pubmed.ncbi.nlm.nih.gov/35444283/
3. Shao, Changjian, Wang, Yuanyong, Pan, Minghong, Ma, Zhiqiang, Yan, Xiaolong. . The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies. In Translational lung cancer research, 10, 4600-4616. doi:10.21037/tlcr-21-973. https://pubmed.ncbi.nlm.nih.gov/35070764/
4. Ghelli Luserna di Rorà, Andrea, Cerchione, Claudio, Martinelli, Giovanni, Simonetti, Giorgia. 2020. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. In Journal of hematology & oncology, 13, 126. doi:10.1186/s13045-020-00959-2. https://pubmed.ncbi.nlm.nih.gov/32958072/
5. Wang, Shuang, Liu, Ximeng, Zhou, Ting, Huang, Yongbo, Li, Xu. 2022. PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity. In Cellular oncology (Dordrecht, Netherlands), 46, 195-209. doi:10.1007/s13402-022-00744-y. https://pubmed.ncbi.nlm.nih.gov/36350496/
6. He, Yaomei, Jiang, Xiulin, Duan, Lincan, Yang, Cuiping, Chen, Yongbin. 2021. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. In Molecular cancer, 20, 156. doi:10.1186/s12943-021-01469-6. https://pubmed.ncbi.nlm.nih.gov/34856993/
7. Yang, Ming, Xiang, Hua, Luo, Guoshun. 2024. Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial. In Journal of medicinal chemistry, 67, 17997-18016. doi:10.1021/acs.jmedchem.4c01619. https://pubmed.ncbi.nlm.nih.gov/39383322/